Angioimmunoblastic T Cell Lymphoma
Showing 1 - 3 of 3
Peripheral T-Cell Lymphoma, Not Otherwise Specified, Angioimmunoblastic T Cell Lymphoma, ALK-negative Anaplastic Large Cell
Unknown status
- Peripheral T-Cell Lymphoma, Not Otherwise Specified
- +5 more
- CEOP/IVE/GDP chemotherapy regimen
- CEOP chemotherapy regimen for 6 cycles
-
Fuzhou, Fujian, China
- +3 more
Mar 7, 2020
ALK-negative Anaplastic Large Cell Lymphoma, Peripherial T Cell Lymphoma,Not Otherwise Specified, Angioimmunoblastic T Cell
Unknown status
- ALK-negative Anaplastic Large Cell Lymphoma
- +5 more
- Cyclophosphamide 750mg/m2
- +8 more
-
Shanghai, Shanghai, ChinaRuijin hospital
Nov 10, 2017
Peripheral T Cell Lymphoma Unspecified, Anaplastic Large Cell Lymphoma, ALK-negative, Angioimmunoblastic T Cell Lymphoma Trial
Completed
- Peripheral T Cell Lymphoma Unspecified
- +3 more
- RAD001 (Everolimus)
-
Goyang-si, Kyoungki-do, Korea, Republic of
- +4 more
Mar 1, 2015